# NAD Supplements: Which Ones Actually Raise NAD in People

By Ruth Calder, Enforcement Editor (https://glpwatchdog.org/authors/ruth-calder) | Published: 2026-11-16

Canonical page: https://glpwatchdog.org/research/nad-supplements-which-raise-levels

> NR and NMN are the NAD supplements with the clearest evidence of raising NAD+ in people: each about doubled whole-blood NAD+ in 14 days in a 2026 trial of 65 adults, and nicotinamide did not. Sublingual NMN did no better than a capsule. Benefits for health remain unproven.

## Key points

- In a 2026 trial of 65 healthy adults, NR and NMN each about doubled whole-blood NAD+ in 14 days; nicotinamide did not.
- NR raised whole-blood NAD+ 22%, 51% and 142% at 100, 300 and 1,000 mg in a company-funded 8-week trial.
- In a 14-person crossover trial, sublingual NMN did not raise blood NAD+ more than swallowed NMN over 60 minutes.
- Most of these trials were funded or staffed by companies selling the ingredient.
- A 2026 systematic review found effects on function and metabolism were mixed and often null.

NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are the NAD supplements with the clearest evidence of raising NAD+ in people. In the first head-to-head trial, 14 days of either one roughly doubled whole-blood NAD+ in healthy adults, and nicotinamide, the cheaper form of vitamin B3, did not.[1] That is a blood result, and it says nothing yet about health. **Across human trials, a higher NAD+ reading has not reliably translated into better function or metabolism.**[10]

> **About this article.** This page covers one question: which products raise NAD+ in human blood. Doses are the ones trials tested, not advice. What NAD+ is and does is explained in [what is NAD+](https://glpwatchdog.org/research/what-is-nad-plus), and health outcomes are in [NAD+ and longevity](https://glpwatchdog.org/research/nad-and-longevity-what-the-trials-show). Most trials here were funded or staffed by a company selling the ingredient, and the table says which.

## Which NAD supplement raises NAD+ the most?

There is no reliable ranking beyond NR and NMN beating nicotinamide, because direct comparisons are so rare. In the 2026 randomized trial that set the three against each other, Nestlé researchers gave 65 healthy adults 1,000 mg of NR, 1,000 mg of NMN, 500 mg of nicotinamide or placebo every day for 14 days. NR raised whole-blood NAD+ by 49.4 µM over placebo and NMN by 43.1 µM, each about a twofold rise, and the authors described the two as comparable. Nicotinamide showed no lasting rise.[1] The trial was open-label, and Nestlé staff ran it.

*Human trials of NAD+ boosters that report blood NAD+. Different assays and populations, so figures cannot be compared across rows.*

| Product | Trial | Daily amount tested | Blood NAD+ result | Company tie |
| --- | --- | --- | --- | --- |
| NR vs NMN vs nicotinamide | 65 healthy adults, 14 days[1] | NR 1,000 mg; NMN 1,000 mg; nicotinamide 500 mg | About 2× on NR and NMN; no lasting rise on nicotinamide | Nestlé authors |
| NR | Overweight adults, 8 weeks[3] | 100, 300 or 1,000 mg | Up 22%, 51% and 142% within 2 weeks | ChromaDex funded |
| NR plus pterostilbene | 120 adults aged 60 to 80, 8 weeks[7] | A labeled dose or double | Up about 40% and 90% at 4 weeks | Elysium Health funded |
| NMN | 80 healthy middle-aged adults, 60 days[4] | 300, 600 or 900 mg | Up in all groups; highest at 600 and 900 mg | Abinopharm and Aba Chemicals authors |
| NMN (MIB-626) | 32 adults aged 55 to 80, 14 days[5] | 1,000 mg once or twice | Substantial dose-related rise | Metro International Biotech authors |
| NMN | 30 healthy adults, 12 weeks[6] | 250 mg | Significant rise over placebo | Mitsubishi Corporation Life Sciences supplied product |
| Niacin (nicotinic acid) | Mitochondrial myopathy patients and matched controls, 4 to 10 months, no placebo[8] | Raised to 750–1,000 mg | Up to 8× in all participants | One author advises ChromaDex, an NR maker |

Rises were larger at higher doses in several of these trials, which is expected and also why percentages from different studies should not be used to pick a brand. Several trials used one named ingredient, such as NIAGEN NR or MIB-626 NMN, so a store-bought bottle may not match what was tested.

## NMN or NR: which is better?

On blood NAD+, the 2026 comparison found the two comparable.[1] The same study offers a reason. When the researchers incubated human blood with each molecule directly, nicotinic acid was a potent NAD+ booster while NMN, NR and nicotinamide were not. Stool bacteria, on the other hand, converted NR and NMN into nicotinic acid. The authors proposed that both supplements raise blood NAD+ partly through the gut, a model built from that lab work and not yet tested as a treatment.[1] If it holds, the two capsules may share much of the same route. How an NMN capsule compares with a clinic drip is a separate question, covered in [NAD+ vs NMN](https://glpwatchdog.org/research/nad-plus-vs-nmn).

## Does nicotinamide or niacin raise NAD+?

Nicotinamide affected the NAD+ pathway only briefly in the head-to-head trial, with no rise after 14 days. It also caused a sharp short-term increase in homocysteine, more than eightfold on one measure.[1] What that means for health at this dose is unknown.

Niacin produced the largest rise in the table, but those amounts are far from a vitamin pill. In a Finnish study, patients with adult-onset mitochondrial myopathy and their matched controls were brought up to 750 to 1,000 mg a day, and blood NAD+ rose as much as eightfold. Muscle strength increased, though there was no placebo group, and some patients tended toward anemia.[8] Too much niacin can raise blood sugar and cause liver damage and peptic ulcers,[17] so this is a finding for researchers and specialists, not a shortcut.

## Is sublingual NMN better than a capsule?

The one direct test says it does not raise NAD+ more. Sublingual tablets are sold on the idea that dissolving under the tongue skips the liver. In a 2026 crossover trial, 14 healthy men took NMN each way once. Over 60 minutes, blood NMN, nicotinamide and NAD+ did not differ between routes. Two breakdown products, 2PY and 4PY, rose faster with the sublingual tablet, and the researchers could not tell where that extra came from.[2] The trial was small, lasted an hour and was run by employees of Meiji.

NADH tablets have mostly been tested for symptoms such as fatigue, in a small and mixed set of trials.[14] None of the trials above tested liposomal products, gummies or patches, so a label claiming better absorption for those forms gets no support from them.

## Does raising NAD+ in blood do anything useful?

That is the weak link. A 2026 systematic review counted 33 human intervention studies and found that NR and NMN consistently hit their biochemical target, while effects on function, metabolism and blood vessels were mixed and often null.[10] A meta-analysis found no support for either in preserving muscle in adults averaging over 60,[11] and pooled NMN trials found no significant benefit on glucose, insulin or lipids.[12] Blood is also an imperfect stand-in for tissue. In 12 older men, NR did raise NAD+ metabolites in muscle, yet mitochondrial energy production did not change.[9]

## Are NAD supplements safe, and are they regulated?

NR and NMN were generally well tolerated over weeks to months.[10] In the 8-week dose trial, NR caused no flushing and no more adverse events than placebo.[3] A review of NADH and precursor trials listed muscle pain, fatigue, sleep disturbance and headaches among reported side effects, none judged a serious risk.[14] Long-term data are missing.

One open question concerns the breakdown products. A 2024 study linked higher blood 2PY and 4PY to more major cardiac events over three years in people with stable heart disease.[13] That study measured metabolites in cardiac patients, not supplement users, so it does not show that NR or NMN causes harm. Anyone with heart disease should raise it with their clinician before taking a booster.

All of these are sold as supplements, and FDA does not have the authority to approve dietary supplements before they are marketed.[15] NMN’s status was disputed until September 29, 2025, when FDA posted a response to a citizen petition from two trade groups, partly granting it and concluding that NMN is not excluded from the supplement category.[16] A supplement label is not evidence of what is in the bottle. For the injected products clinics sell under the same name, see [NAD+ injections](https://glpwatchdog.org/research/nad-injections-what-the-evidence-shows), and for sellers, the [NAD+ profile](https://glpwatchdog.org/peptides/nad).

## Frequently asked questions

### What is the best NAD supplement?

No trial has identified a single best product. NR and NMN both raised whole-blood NAD+ about twofold in a 2026 head-to-head trial, and nicotinamide did not. Most trials used one company's ingredient, so results may not apply to other brands.

### Do NAD supplements actually work?

They raise NAD+ in the blood. Whether that improves health is a different matter: across 33 human studies, a 2026 systematic review saw mixed and often null effects on function and metabolism.

### Which is better, NMN or NR?

In a 2026 randomized trial of 65 healthy adults, 1,000 mg a day of either raised whole-blood NAD+ by a similar amount over 14 days. Neither has been shown to be better for health. The trial was run by Nestlé researchers.

### How long does it take NAD supplements to raise levels?

Trials have measured higher blood NAD+ within about two weeks of daily NR or NMN. A rise in blood does not mean you will notice any change in how you feel.

### Does sublingual NMN work better than regular NMN?

Not on current evidence. In a 14-person crossover trial, blood NAD+ did not differ between sublingual and swallowed NMN over 60 minutes. Only two breakdown products rose faster with the sublingual form.

### What are the side effects of NAD supplements?

Short trials of NR and NMN found them generally well tolerated. Reported complaints include headache, fatigue, muscle pain and poor sleep. High-dose niacin carries more risk, including raised blood sugar and liver damage. Long-term safety has not been established.

## References

1. Christen S, Redeuil K, Goulet L, Giner MP, et al. The differential impact of three different NAD(+) boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism. 2026. PMID: 41540253. DOI: 10.1038/s42255-025-01421-8. https://pubmed.ncbi.nlm.nih.gov/41540253/
2. Wakabayashi J, Higashi S, Morifuji M. Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. Scientific Reports. 2026. PMID: 42304075. DOI: 10.1038/s41598-026-57552-9. https://pubmed.ncbi.nlm.nih.gov/42304075/
3. Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports. 2019. PMID: 31278280. DOI: 10.1038/s41598-019-46120-z. https://pubmed.ncbi.nlm.nih.gov/31278280/
4. Yi L, Maier AB, Tao R, Lin Z, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023. PMID: 36482258. DOI: 10.1007/s11357-022-00705-1. https://pubmed.ncbi.nlm.nih.gov/36482258/
5. Pencina KM, Lavu S, Dos Santos M, Beleva YM, et al. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults. Journals of Gerontology: Series A. 2023. PMID: 35182418. DOI: 10.1093/gerona/glac049. https://pubmed.ncbi.nlm.nih.gov/35182418/
6. Okabe K, Yaku K, Uchida Y, Fukamizu Y, et al. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Frontiers in Nutrition. 2022. PMID: 35479740. DOI: 10.3389/fnut.2022.868640. https://pubmed.ncbi.nlm.nih.gov/35479740/
7. Dellinger RW, Santos SR, Morris M, Evans M, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. NPJ Aging and Mechanisms of Disease. 2017. PMID: 29184669. DOI: 10.1038/s41514-017-0016-9. https://pubmed.ncbi.nlm.nih.gov/29184669/
8. Pirinen E, Auranen M, Khan NA, Brilhante V, et al. Niacin Cures Systemic NAD(+) Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. Cell Metabolism. 2020. PMID: 32386566. DOI: 10.1016/j.cmet.2020.04.008. https://pubmed.ncbi.nlm.nih.gov/32386566/
9. Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD(+) Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports. 2019. PMID: 31412242. DOI: 10.1016/j.celrep.2019.07.043. https://pubmed.ncbi.nlm.nih.gov/31412242/
10. Gallagher C, Emmanuel OO. NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews. 2026. PMID: 41655607. DOI: 10.1016/j.arr.2026.103057. https://pubmed.ncbi.nlm.nih.gov/41655607/
11. Prokopidis K, Moriarty F, Bahat G, McLean J, et al. The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle. 2025. PMID: 40275690. DOI: 10.1002/jcsm.13799. https://pubmed.ncbi.nlm.nih.gov/40275690/
12. Chen F, Zhou D, Kong AP, Yim NT, et al. Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Current Diabetes Reports. 2024. PMID: 39531138. DOI: 10.1007/s11892-024-01557-z. https://pubmed.ncbi.nlm.nih.gov/39531138/
13. Ferrell M, Wang Z, Anderson JT, Li XS, et al. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nature Medicine. 2024. PMID: 38374343. DOI: 10.1038/s41591-023-02793-8. https://pubmed.ncbi.nlm.nih.gov/38374343/
14. Gindri IM, Ferrari G, Pinto LPS, Bicca J, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. American Journal of Physiology: Endocrinology and Metabolism. 2024. PMID: 37971292. DOI: 10.1152/ajpendo.00242.2023. https://pubmed.ncbi.nlm.nih.gov/37971292/
15. U.S. Food and Drug Administration Questions and Answers on Dietary Supplements. FDA. 2026. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
16. U.S. Food and Drug Administration Response Letter from FDA to Natural Products Association and Alliance for Natural Health USA (citizen petition on NMN), docket FDA-2023-P-0872. Regulations.gov. 2025. https://downloads.regulations.gov/FDA-2023-P-0872-2754/attachment_1.pdf
17. MedlinePlus, National Library of Medicine Niacin. MedlinePlus Medical Encyclopedia. 2026. https://medlineplus.gov/ency/article/002409.htm

---

Cite as: GLP Watchdog, Ruth Calder, "NAD Supplements: Which Ones Actually Raise NAD in People", published 2026-11-16. https://glpwatchdog.org/research/nad-supplements-which-raise-levels

Canonical HTML page: https://glpwatchdog.org/research/nad-supplements-which-raise-levels

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.
